176 related articles for article (PubMed ID: 6914790)
1. [Infectious complications in the endangered host patient].
Leibowitz RE
Rev Enferm; 1981 Aug; 4 Suppl(38):10, 12-14. PubMed ID: 6914790
[No Abstract] [Full Text] [Related]
2. The role of cellular and humoral factors in infections.
Neu HC
Clin Haematol; 1976 Jun; 5(2):449-65. PubMed ID: 780033
[No Abstract] [Full Text] [Related]
3. [The patient with impaired defense against infections. Types of defect and spectrum of infectious diseases].
Frøland SS
Tidsskr Nor Laegeforen; 1983 Jan; 103(3):213-9. PubMed ID: 6687768
[No Abstract] [Full Text] [Related]
4. Infections in the immunocompromised host.
Solberg CO
Scand J Infect Dis Suppl; 1980; Suppl 24():36-43. PubMed ID: 6782661
[No Abstract] [Full Text] [Related]
5. Immunity to microbes: lessons from primary immunodeficiencies.
Carneiro-Sampaio M; Coutinho A
Infect Immun; 2007 Apr; 75(4):1545-55. PubMed ID: 17283094
[No Abstract] [Full Text] [Related]
6. Cell-mediated immunity and resistance to infection: report of a WHO scientific group.
World Health Organ Tech Rep Ser; 1973; 519():1-64. PubMed ID: 4634151
[No Abstract] [Full Text] [Related]
7. Toll-Like receptors (TLRs) and their ligands.
Uematsu S; Akira S
Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
[TBL] [Abstract][Full Text] [Related]
8. Of microbes, macrophages and nitric oxide.
Bogdan C
Behring Inst Mitt; 1997 Mar; (99):58-72. PubMed ID: 9303203
[TBL] [Abstract][Full Text] [Related]
9. [The immune response in pediatric infections].
Martín Mateos MA
An Esp Pediatr; 1989 Sep; 31 Suppl 38():20-4. PubMed ID: 2490620
[No Abstract] [Full Text] [Related]
10. [Immune mechanisms of antiviral, bacterial and parasitic protection].
Olinescu A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(1):15-28. PubMed ID: 3057582
[No Abstract] [Full Text] [Related]
11. Infection and the older patient.
Abramson C
Clin Podiatr Med Surg; 1993 Apr; 10(2):249-69. PubMed ID: 8481882
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial activity of NK cells].
Cavallo R
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):35-46. PubMed ID: 7498615
[TBL] [Abstract][Full Text] [Related]
13. [Factors and mechanisms which favor the appearance of infections caused by bacteria and fungi with conditioned pathogenicity].
Duca E
Microbiol Parazitol Epidemiol (Bucur); 1972; 17(1):23-9. PubMed ID: 5018851
[No Abstract] [Full Text] [Related]
14. Soluble IL-4 receptor, potential for therapeutic and prophylactic intervention.
Gessner A; Röllinghoff M
Behring Inst Mitt; 1994 Dec; (95):35-41. PubMed ID: 7755507
[TBL] [Abstract][Full Text] [Related]
15. Implications of early apoptosis of infected cells as an important host defense.
LeGrand EK
Med Hypotheses; 2000 Apr; 54(4):591-6. PubMed ID: 10859645
[TBL] [Abstract][Full Text] [Related]
16. Host-pathogen interactions: pas de deux.
Pearce EJ; Schofield L
Curr Opin Immunol; 2007 Aug; 19(4):373-5. PubMed ID: 17702557
[No Abstract] [Full Text] [Related]
17. Survival of pathogenic organisms in immunocompetent hosts.
Cohen S
Chemioterapia; 1985 Aug; 4(4):329-38. PubMed ID: 2414017
[TBL] [Abstract][Full Text] [Related]
18. Natural regulatory T cells in infectious disease.
Belkaid Y; Rouse BT
Nat Immunol; 2005 Apr; 6(4):353-60. PubMed ID: 15785761
[TBL] [Abstract][Full Text] [Related]
19. Molecular machinations: chemokine signals in host-pathogen interactions.
Chensue SW
Clin Microbiol Rev; 2001 Oct; 14(4):821-35, table of contents. PubMed ID: 11585787
[TBL] [Abstract][Full Text] [Related]
20. [Immune response to antibiotics in patients with secondary immunodeficiencies].
Meroni PL
J Chemother; 1994 Aug; 6 Suppl 3():16-8. PubMed ID: 7861203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
